BECN1 and breast carcinoma: Wang et al. demonstrated that co-treatment of curcumin and berberine suppresses the development of breast cancer cells by causing autophagic cell death via the JNK/Bcl-2/Beclin1 pathway and caspase-dependent apoptosis via ERK.